rs201728165
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 1P and 5B. PP2BP4_StrongBP6
The NM_001267550.2(TTN):c.20743G>T(p.Ala6915Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000062 in 1,612,938 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001267550.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTN | NM_001267550.2 | c.20743G>T | p.Ala6915Ser | missense_variant | 71/363 | ENST00000589042.5 | NP_001254479.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTN | ENST00000589042.5 | c.20743G>T | p.Ala6915Ser | missense_variant | 71/363 | 5 | NM_001267550.2 | ENSP00000467141.1 |
Frequencies
GnomAD3 genomes AF: 0.000375 AC: 57AN: 152164Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000685 AC: 17AN: 248048Hom.: 0 AF XY: 0.0000669 AC XY: 9AN XY: 134588
GnomAD4 exome AF: 0.0000301 AC: 44AN: 1460656Hom.: 0 Cov.: 31 AF XY: 0.0000303 AC XY: 22AN XY: 726548
GnomAD4 genome AF: 0.000368 AC: 56AN: 152282Hom.: 0 Cov.: 33 AF XY: 0.000457 AC XY: 34AN XY: 74450
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Nov 21, 2017 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 14, 2021 | This variant is associated with the following publications: (PMID: 25447171) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jun 30, 2023 | - - |
not specified Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Aug 22, 2014 | Ala5671Ser in exon 68 of TTN: This variant is not expected to have clinical sign ificance due to a lack of conservation across species, including mammals. Of not e, 4 mammals (Tibetan antelope, cow, sheep and domestic goat) and 2 fish (stickl eback and atlantic cod) have a serine (Ser) at this position despite high nearby amino acid conservation. In addition, this variant has been identified in 0.2% (6/3820) of African American chromosomes by the NHLBI Exome Sequencing Project ( http://evs.gs.washington.edu/EVS/; dbSNP rs201728165). - |
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Apr 29, 2014 | - - |
TTN-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 30, 2024 | The TTN c.20743G>T variant is predicted to result in the amino acid substitution p.Ala6915Ser. This variant has been reported in a case of sudden cardiac death (described as p.A5671S in case #16, Campuzano et al. 2014. PubMed ID: 25447171). However, this individual also harbored additional variants, including two other TTN missense variants. This variant is reported in 0.13% of alleles in individuals of African descent in gnomAD, which may be too common to be an undocumented primary cause of disease. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Autosomal recessive limb-girdle muscular dystrophy type 2J;C1858763:Dilated cardiomyopathy 1G Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at